TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $664,367 | -43.5% | 74,314 | -3.0% | 0.08% | -41.4% |
| Q2 2023 | $1,176,806 | -34.6% | 76,615 | -4.3% | 0.14% | -40.6% |
| Q1 2023 | $1,800,325 | +1.9% | 80,050 | -4.7% | 0.24% | -7.2% |
| Q4 2022 | $1,766,036 | -17.7% | 83,977 | -3.6% | 0.26% | -19.1% |
| Q3 2022 | $2,145,000 | +1.5% | 87,068 | -0.2% | 0.32% | +5.5% |
| Q2 2022 | $2,114,000 | -11.5% | 87,266 | -5.8% | 0.31% | +16.2% |
| Q1 2022 | $2,388,000 | -48.4% | 92,653 | -37.8% | 0.26% | -32.2% |
| Q4 2021 | $4,627,000 | +25.7% | 149,077 | -1.8% | 0.39% | +20.7% |
| Q3 2021 | $3,682,000 | +62.8% | 151,839 | -2.0% | 0.32% | +64.5% |
| Q2 2021 | $2,261,000 | -44.6% | 154,968 | -5.1% | 0.20% | -48.2% |
| Q1 2021 | $4,079,000 | +22.6% | 163,371 | +33.8% | 0.38% | +29.7% |
| Q4 2020 | $3,327,000 | – | 122,076 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |